These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1837695)

  • 1. Effects of tryptophan on the development of deoxycorticosterone acetate (DOCA)-induced hypertension in rats.
    Fregly MJ
    Adv Exp Med Biol; 1991; 294():619-23. PubMed ID: 1837695
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic dietary administration of tryptophan prevents the development of deoxycorticosterone acetate salt induced hypertension in rats.
    Fregly MJ; Lockley OE; van der Voort J; Sumners C; Henley WN
    Can J Physiol Pharmacol; 1987 May; 65(5):753-64. PubMed ID: 3621037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic dietary treatment with nicotinic acid on the development and maintenance of deoxycorticosterone-acetate-salt-induced hypertension.
    Fregly MJ; Lockley OE; Torres JL; Cade JR
    Pharmacology; 1988; 37(1):50-68. PubMed ID: 3420163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of DOCA-induced hypertension in rats by chronic treatment with tryptophan.
    Fregly MJ; Fater DC
    Clin Exp Pharmacol Physiol; 1986; 13(11-12):767-76. PubMed ID: 2951040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic dietary treatment with 1-tryptophan on spontaneous salt appetite of rats.
    Fregly MJ; Rowland NE; Sumners C
    Pharmacol Biochem Behav; 1989 Jun; 33(2):401-6. PubMed ID: 2813478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central serotonergic alterations in deoxycorticosterone acetate/NaCl (DOCA/NaCl)-induced hypertension.
    Dawson R; Nagamhama S; Oparil S
    Neuropharmacology; 1988 Apr; 27(4):417-26. PubMed ID: 3419540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of Fischer 344 rats to deoxycorticosterone hypertension.
    Hall CE; Hall O
    Life Sci; 1977 Apr; 20(7):1239-47. PubMed ID: 850474
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic treatment with L-5-hydroxytryptophan prevents the development of DOCA-salt-induced hypertension in rats.
    Fregly MJ; Lockley OE; Sumners C
    J Hypertens; 1987 Oct; 5(5):621-8. PubMed ID: 2963066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
    Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG
    Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural change in the rat hindlimb during deoxycorticosterone acetate hypertension; its reversibility and prevention.
    Vial JH; Yong AC; Boyd GW
    J Hypertens; 1989 Feb; 7(2):143-50. PubMed ID: 2522477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antihypertensive effect of taurine in DOCA-salt rats.
    Fujita T; Sato Y
    J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
    Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
    J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of hypertension and cardiac hypertrophy in guinea pig by DOCA salt.
    Tiritilli A; Ruff F
    Methods Find Exp Clin Pharmacol; 1994; 16(6):391-6. PubMed ID: 7837830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental hypertension and other responses to 18-hydroxy-deoxycorticosterone treatment in the rat.
    Hall CE; Gomez-Sanchez CE; Holland OB; Nasseth D; Hall O
    Endocrinology; 1978 Jul; 103(1):133-40. PubMed ID: 744064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
    Fujita T; Sato Y
    Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of cardiac dysfunction by selective ET-A receptor antagonism.
    Allan A; Fenning A; Levick S; Hoey A; Brown L
    Br J Pharmacol; 2005 Nov; 146(6):846-53. PubMed ID: 16151437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
    Li M; Martin A; Liu DT; Whitworth JA
    J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic dietary treatment with L-tryptophan on the maintenance of hypertension in spontaneously hypertensive rats.
    Fregly MJ; Sumners C; Cade JR
    Can J Physiol Pharmacol; 1989 Jun; 67(6):656-62. PubMed ID: 2776081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertensinogenic potencies of aldosterone and deoxycorticosterone in the rat.
    Komanicky P; Melby JC
    Hypertension; 1982; 4(1):140-5. PubMed ID: 7061121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.